TURSG:BISTTurkiye Sigorta A.S. Analysis
Data as of 2026-03-12 - not real-time
TRY 12.59
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The short‑term moving average sits above the mid‑term and long‑term averages, confirming a bullish alignment, while the momentum indicator remains in the upper half of its range, suggesting room for further upside. The price is comfortably above the nearest support level and below the next resistance, but the recent decline in trading volume adds a note of caution.
Fundamental backdrop: Revenue is expanding at a robust pace and profitability metrics are solid, with margins well above industry norms. Cash balances dwarf the modest debt load, supporting a healthy dividend payout that appears sustainable. Forward earnings estimates point to a sharp earnings acceleration, and discounted cash‑flow analysis signals a sizable valuation gap, making the stock attractive despite a lofty trailing price‑earnings multiple.
Fundamental backdrop: Revenue is expanding at a robust pace and profitability metrics are solid, with margins well above industry norms. Cash balances dwarf the modest debt load, supporting a healthy dividend payout that appears sustainable. Forward earnings estimates point to a sharp earnings acceleration, and discounted cash‑flow analysis signals a sizable valuation gap, making the stock attractive despite a lofty trailing price‑earnings multiple.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish moving‑average hierarchy
- Price positioned between support and resistance
- Decreasing volume suggesting caution
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth and high margins
- Undervaluation indicated by DCF and forward earnings
- Sustainable dividend with low payout ratio
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- High return on equity and robust cash generation
- Low beta implying limited market volatility
- Attractive dividend yield and long‑term earnings expansion
Key Metrics & Analysis
Financial Health
Revenue Growth41.90%
Profit Margin22.18%
P/E Ratio52.5
ROE50.52%
ROA12.83%
Debt/Equity0.29
P/B Ratio2.5
Op. Cash FlowTRY9.4B
Free Cash FlowTRY-12589299712
Industry P/E16.6
Technical Analysis
TrendBullish
RSI57.6
SupportTRY 11.20
ResistanceTRY 13.06
MA 20TRY 12.38
MA 50TRY 12.07
MA 200TRY 10.66
MACDBearish
VolumeDecreasing
Fear & Greed Index76.3
Valuation
Fair ValueTRY 34.66
Target PriceTRY 16.52
Upside/Downside31.22%
GradeUndervalued
TypeGrowth
Dividend Yield1.63%
Risk Assessment
Beta0.18
Volatility26.13%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.